Publications by authors named "Shuko Hirota"

Claim this Profile
C
Clinical significance of histological inflammation in systemic sclerosis-associated interstitial lung disease.
Shuko Hirota, Yasuhiko Yamano, Reoto Takei, Jun Fukihara, Hajime Sasano

Respir Investig· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Experience of the Comparative Effectiveness and Safety of Molnupiravir and Nirmatrelvir/Ritonavir in High-Risk Patients with COVID-19 in a Community Setting.
Yoshikazu Mutoh, Takumi Umemura, Takeshi Nishikawa, Kaho Kondo, Yuta Nishina, Shuko Hirota

Viruses· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of monoclonal antibody therapy for COVID-19 patients using a risk scoring system.
Yoshikazu Mutoh, Takumi Umemura, Aiko Ota, Keisuke Okuda, Ryoma Moriya, Shuko Hirota

J Infect Chemother· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical utility of the C-reactive protein:albumin ratio in non-small cell lung cancer patients treated with nivolumab.
Taisuke Araki, Kazunari Tateishi, Kei Sonehara, Shuko Hirota, Masamichi Komatsu

Thorac Cancer· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fatal Primary Human Bocavirus Pneumonia in an Immunocompetent Adult.
Takashi Ishiguro, Shuko Hirota, Yasuhito Kobayashi, Kenji Takano, Yoichi Kobayashi

Intern Med· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Successful Treatment of Squamous Cell Lung Cancer without PD-L1 Expression Using Fourth-Line Nivolumab].
Ryota Ozawa, Hiroshi Kuraishi, Shuko Hirota, Manabu Yamamoto, Takeshi Masubuchi

Gan To Kagaku Ryoho· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allergic bronchopulmonary aspergillosis successfully treated with mepolizumab: Case report and review of the literature.
Shuko Hirota, Yoichi Kobayashi, Takashi Ishiguro, Takashi Nishida, Naho Kagiyama

Respir Med Case Rep· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis